Ozempic, Weight Loss

GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...
The biotech said it would use the cash to “further accelerate” a portfolio led by its GLP-1 receptor agonist MET-097 ..
Recent studies have shown that pharmacological treatment with GLP-1-RA and dual GLP-1/glucose-dependent insulinotropic ...
The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a ...
Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...
SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
BOULDER, CO / ACCESSWIRE / November 14, 2024 / Informa Market's New Hope Network and Nutrition Business Journal (NBJ) unveil ...
As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new ...
In addition to ensuring equitable access to the glucagon-like peptide-1 (GLP-1) receptor agonists ... primarily ...
Poorer folks' access to blockbuster weight-loss drugs through Medicaid remains ... treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discovered.